M Holdings Securities, Inc. Novo Nordisk A S Transaction History

M Holdings Securities, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $38,378 - $46,150	-290 Reduced 13.27%	1,895 $302,000
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $10,255 - $13,533	-100 Reduced 4.38%	2,185 $296,000
Q3 2022 Nov 16, 2022	SELL	$95.28 - $116.93 $15,721 - $19,293	-165 Reduced 6.73%	2,285 $228,000
Q2 2022 Aug 16, 2022	SELL	$103.24 - $121.81 $4,749 - $5,603	-46 Reduced 1.84%	2,450 $273,000
Q1 2022 May 24, 2022	BUY	$93.1 - $112.54 $232,377 - $280,899	2,496 New	2,496 $277,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.